+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Capillary blood glucose screening (Accu-Chek Advantage) for gestational diabetes

Capillary blood glucose screening (Accu-Chek Advantage) for gestational diabetes

Journal of the Medical Association of Thailand 92(10): 1268-1272

To determine optimal threshold of capillary blood glucose screening (Accu-Chek Advantage) for gestational diabetes. A cross-sectional analytical study. Capillary and venous blood of pregnant women who attended the antenatal clinic at Trang Regional Hospital between August 2007 and May 2008 were collected for glucose testing (by approach of American Diabetes Association's Fourth International Workshop-Conference on Gestational Diabetes) at one hour after taking 50 gm glucose. The glucose values of Accu-Check Advantage were compared with the standard venous plasma glucose. The receiver operator characteristic (ROC) curve was created to determine the optimal threshold of the capillary blood test screening for gestational diabetes. A total of 816 pregnant women were enrolled in the present study. Their capillary blood glucose values and plasma glucose values were checked with the Accu-Chek Advantage and the central laboratory chemistry analyzer respectively. The good correlation between capillary blood glucose and plasma glucose values was found (correlation coefficient = 0.80, 95% CI 0.77-0.82). There was a significant difference in the average values of capillary blood and plasma blood (134.1 vs. 122.7 mg/dl, respectively). When the data were analyzed by ROC curve, the optimal level of capillary blood by Accu-Chek Advantage for performing a 100 gm oral glucose tolerance test was 140 mg/dl (reference plasma glucose level of at least 140 mg/dl). The sensitivity specificity likelihood ratio for a positive test result and likelihood ratio for a negative test result were 93.8%, 83.6%, 5.71 and 0.07, respectively. The potential advantages of capillary blood glucose screening are simple to use, cheap and convenient. Accu-Chek Advantage is suitable for screening gestational diabetes using the optimal threshold capillary glucose level of 140 mg/dl.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 051930698

Download citation: RISBibTeXText

PMID: 19845232

Related references

Performance of the Roche Accu-Chek active glucose meter to screen for gestational diabetes mellitus using fasting capillary blood. Diabetes Technology & Therapeutics 13(12): 1229-1233, 2012

Capillary blood evaluation of the Accu-Chek advantage blood glucose monitoring system. Clinical Chemistry 42(6 PART 2): S149-S150, 1996

A glucose meter accuracy and precision comparison: the FreeStyle Flash Versus the Accu-Chek Advantage, Accu-Chek Compact Plus, Ascensia Contour, and the BD Logic. Diabetes Technology & Therapeutics 10(2): 102-110, 2008

Performance of the AccuData GTS advantage with the Accu-Chek Advantage H Strip using venous, capillary, and arterial blood samples. Clinical Chemistry 42(6 PART 2): S149, 1996

An evaluation of the Accu-Chek Advantage blood glucose monitoring system. Clinical Chemistry 41(S6 PART 2): S192, 1995

Performance evaluation of the Accu-Chek Advantage H new generation test strip using venous and capillary blood samples. Clinical Chemistry 43(6 PART 2): S117, 1997

Multicenter evaluation of neonatal and cord whole blood glucose using the ACCU-CHEK Advantage system. Clinical Chemistry 42(6 PART 2): S144, 1996

Comparison study of Accu-Chek Advantage and Precision QID meters with i-Stat as reference method using same finger tip capillary blood. Clinical Chemistry 45(6 PART 2): A33, June, 1999

Precision and accuracy of the Accu-Chek Advantage blood glucose monitoring system at high altitude. Clinical Chemistry 42(1): 115-117, 1996

Comparison of arterial and capillary blood glucose with the use of the Accu-Chek III. Progress in Cardiovascular Nursing 10(4): 27-30, 1995

A comparative evaluation of two sensor type blood glucose monitoring systems Accuracy and precision of the Accu-Chek Advantage-TM and Medisense Companion 2-TM. Clinical Chemistry 40(6): 1061, 1994

Analytical evaluation of the Accu-Chek Advantage monitor for point-of-care glucose testing. Clinical Chemistry 42(6 PART 2): S160, 1996

Comparison of capillary Accu-Chek blood glucose values to laboratory values. American Journal of Perinatology 6(3): 334-336, 1989

Monitoring neonatal hypoglycemia with the Accu-chek advantage II glucose meter: the cautionary tale of galactosemia. Clinical Chemistry 48(11): 2071-2071, 2002

Evaluation of Lifescan SureStepFlexx and Roche Accu-Chek Advantage glucose meters for use in neonatal care. Clinical Chemistry 49(S6): A152, June, 2003